Prostate Health Supplement

Super Beta Prostate P3 Advanced

240 adverse event reports submitted to the FDA · 2017–2021 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 240 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Blood urine present
58
Urinary retention
23
Haemorrhage
12
Myocardial infarction
12
Dyspnoea
12
Cerebrovascular accident
11
Hypertension
11
Dizziness
11
Nephrolithiasis
9
Pain
8

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

OutcomeReports
Other Serious or Important Medical Event 165
Other Serious Outcome 83
Hospitalization 57
Visited Emergency Room 43
Visited a Health Care Provider 25
Death 3
Other Outcome 1
Life Threatening 1
Congenital Anomaly 1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18
0
18–34
0
35–49
2
50–64
25
65–79
54
80+
28
Unknown
131

109 reports had age data; 131 unknown.

Gender

Male
220
Unknown/Not Reported
20

Reports by Year

Annual report counts from 2017–2021. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'17
'18
'19
'20
'21

Hover bars for exact counts.

Context about this data: Reports concentrated in 2018–2019, reflecting the initial reporting period following product launch.

← View all Super Beta products in FDA data

Related Products

Super Beta Prostate (1,108) Super Beta Virility Boost (145)

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗  ·  About our methodology  ·  How to read this data